Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CHROMOSOMAL BREAKPOINT' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 157 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Buckley, AR
      Prolactin, a lymphocyte growth and survival factor

      LUPUS
    2. Howard, JC; Li, Q; Chu, W; Zochodne, B; Kapoor, M; Ung, Y; Rosen, K; Ben-David, Y
      Bcl-2 expression in F-MuLV-induced erythroleukemias: a role for the anti-apoptotic action of Bcl-2 during tumor progression

      ONCOGENE
    3. Daadi, MM; Saporta, S; Willing, AE; Zigova, T; McGrogan, MP; Sanberg, PR
      In vitro induction and in vivo expression of bcl-2 in the hNT neurons

      BRAIN RESEARCH BULLETIN
    4. Saintigny, Y; Dumay, A; Lambert, S; Lopez, BS
      A novel role for the Bcl-2 protein family: specific suppression of the RAD51 recombination pathway

      EMBO JOURNAL
    5. Petros, AM; Medek, A; Nettesheim, DG; Kim, DH; Yoon, HS; Swift, K; Matayoshi, ED; Oltersdorf, T; Fesik, SW
      Solution structure of the antiapoptotic protein bcl-2

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    6. Jin, KL; Graham, SH; Mao, XO; He, XJ; Nagayama, T; Simon, RP; Greenberg, DA
      Bax kappa, a novel Bax splice variant from ischemic rat brain lacking an ART domain, promotes neuronal cell death

      JOURNAL OF NEUROCHEMISTRY
    7. Wang, NS; Unkila, MT; Reineks, EZ; Distelhorst, CW
      Transient expression of wild-type or mitochondrially targeted Bcl-2 induces apoptosis, whereas transient expression of endoplasmic reticulum-targetedBcl-2 is protective against Bax-induced cell death

      JOURNAL OF BIOLOGICAL CHEMISTRY
    8. Welzel, N; Le, T; Marculescu, R; Mitterbauer, G; Chott, A; Pott, C; Kneba, M; Du, MQ; Kusec, R; Drach, J; Raderer, M; Mannhalter, C; Lechner, K; Nadel, B; Jaeger, U
      Templated nucleotide addition and immunoglobulin J(H)-gene utilization in t(11;14) junctions: Implications for the mechanism of translocation and theorigin of mantle cell lymphoma

      CANCER RESEARCH
    9. Knudson, CM; Johnson, GM; Lin, Y; Korsmeyer, SJ
      Bax accelerates tumorigenesis in p53-deficient mice

      CANCER RESEARCH
    10. Yasukawa, M; Bando, S; Dolken, G; Sada, E; Yakushijin, Y; Fujita, S; Makino, H
      Low frequency of BCL-2/J(H) translocation in peripheral blood lymphocytes of healthy Japanese individuals

      BLOOD
    11. Gotow, T; Shibata, M; Kanamori, S; Tokuno, O; Ohsawa, Y; Sato, N; Isahara, K; Yayoi, Y; Watanabe, T; Leterrier, JF; Linden, M; Kominami, E; Uchiyama, Y
      Selective localization of Bcl-2 to the inner mitochondrial and smooth endoplasmic reticulum membranes in mammalian cells

      CELL DEATH AND DIFFERENTIATION
    12. Tsujimoto, Y; Shimizu, S
      VDAC regulation by the Bcl-2 family of proteins

      CELL DEATH AND DIFFERENTIATION
    13. Charalambous, GK; Gomatos, IP; Konstadoulakis, MM; Messaris, EG; Manouras, AJ; Apostulou, AE; Leandros, EA; Karayannis, MK; Androulakis, GA
      Protein expression of bax, bcl-2, and p53 in patients with non-Hodgkin's gastric lymphoma: Prognostic significance

      WORLD JOURNAL OF SURGERY
    14. Tsujimoto, Y
      Role of anti-apoptotic Bcl-2 protein in spinal muscular atrophy

      JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT
    15. Hirt, C; Dolken, G
      Quantitative detection of t(14;18)-positive cells in patients with follicular lymphoma before and after autologous bone marrow transplantation

      BONE MARROW TRANSPLANTATION
    16. Ito, Y; Takeda, T; Sasaki, Y; Sakon, M; Monden, M; Yamada, T; Ishiguro, S; Imaoka, S; Tsujimoto, M; Matsuura, N
      bcl-2 expression in cholangiocellular carcinoma is inversely correlated with biologically aggressive phenotypes

      ONCOLOGY
    17. Mancuso, T; Mezzelani, A; Riva, C; Fabbri, A; Dal Bo, L; Sampietro, G; Perego, P; Casali, P; Zunino, F; Sozzi, G; Pierotti, MA; Pilotti, S
      Analysis of SYT-SSX fusion transcripts and bcl-2 expression and phosphorylation status in synovial sarcoma

      LABORATORY INVESTIGATION
    18. Koch, P; Bohlmann, I; Schafer, M; Hansen-Hagge, TE; Kiyoi, H; Wilda, M; Hameister, H; Bartram, CR; Janssen, JWG
      Identification of a novel putative Ran-binding protein and its close homologue

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    19. Scheerer, JB; Xi, LQ; Knapp, GW; Setzer, RW; Bigbee, WL; Fuscoe, JC
      Quantification of illegitimate V(D)J recombinase-mediated mutations in lymphocytes of newborns and adults

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    20. Yoshida, S; Kaneita, Y; Aoki, Y; Seto, M; Mori, S; Moriyama, M
      Identification of heterologous translocation partner genes fused to the BCL6 gene in diffuse large B-cell lymphomas: 5 '-RACE and LA-PCR analyses of biopsy samples

      ONCOGENE
    21. Fang, JM; Finn, WG; Hussong, JW; Goolsby, CL; Cubbon, AR; Variakojis, D
      CD10 antigen expression correlates with the t(14;18)(q32;q21) major breakpoint region in diffuse large B-cell lymphoma

      MODERN PATHOLOGY
    22. Suzukawa, K; Kodera, T; Shimizu, S; Nagasawa, T; Asou, H; Kamada, N; Taniwaki, M; Yokota, J; Morishita, K
      Activation of EVI1 transcripts with chromosomal translocation joining the TCRV beta locus and the EVI1 gene in human acute undifferentiated leukemia cell line (Kasumi-3) with a complex translocation of der(3)t(3;7;8)

      LEUKEMIA
    23. Corradini, P; Ladetto, M; Pileri, A; Tarella, C
      Clinical relevance of minimal residual disease monitoring in non-Hodgkin'slymphomas: a critical reappraisal of molecular strategies

      LEUKEMIA
    24. Mostafapour, SP; Hockenbery, DM; Rubel, EW
      Life and death in otolaryngology - Mechanisms of apoptosis and its role inthe pathology and treatment of disease

      ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
    25. Leahy, DT; Mulcahy, HE; O'Donoghue, DP; Parfrey, NA
      bcl-2 protein expression is associated with better prognosis in colorectalcancer

      HISTOPATHOLOGY
    26. Gribben, JG
      Bone marrow transplant for lymphoma: where is the field going?

      BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
    27. Christensen, JG; Romach, EH; Healy, LN; Gonzales, AJ; Anderson, SP; Malarkey, DE; Corton, JC; Fox, TR; Cattley, RC; Goldsworthy, TL
      Altered bcl-2 family expression during non-genotoxic hepatocarcinogenesis in mice

      CARCINOGENESIS
    28. Dong, LA; Wang, WL; Wang, F; Stoner, M; Reed, JC; Harigai, M; Samudio, I; Kladde, MP; Vyhlidal, C; Safe, S
      Mechanisms of transcriptional activation of bcl-2 gene expression by 17 beta-estradiol in breast cancer cells

      JOURNAL OF BIOLOGICAL CHEMISTRY
    29. Morita, Y; Tilly, JL
      Oocyte apoptosis: Like sand through an hourglass

      DEVELOPMENTAL BIOLOGY
    30. Eguchi, Y; Srinivasan, A; Tomaselli, KJ; Shimizu, S; Tsujimoto, Y
      ATP-dependent steps in apoptotic signal transduction

      CANCER RESEARCH
    31. Indraccolo, S; Minuzzo, S; Nicoletti, L; Cretella, E; Simon, M; Papakonstantinou, G; Hehlmann, R; Mion, M; Bertorelle, R; Roganovic, J; Chieco-Bianchi, L
      Mutator phenotype in human hematopoietic neoplasms and its association with deletions disabling DNA repair genes and bcl-2 rearrangements

      BLOOD
    32. KRUMENACKER JS; BUCKLEY DJ; LEFF MA; MCCORMACK JT; DEJONG G; GOUT PW; REED JC; MIYASHITA T; MAGNUSON NS; BUCKLEY AR
      PROLACTIN-REGULATED APOPTOSIS OF NB2 LYMPHOMA-CELLS - PIM-1, BCL-2, AND BAX EXPRESSION

      ENDOCRINE
    33. MONNI O; OINONEN R; ELONEN E; FRANSSILA K; TEERENHOVI L; JOENSUU H; KNUUTILA S
      GAIN OF 3Q AND DELETION OF 11Q22 ARE FREQUENT ABERRATIONS IN MANTLE CELL LYMPHOMA

      Genes, chromosomes & cancer
    34. CHRISTENSEN JG; GONZALES AJ; CATTLEY RC; GOLDSWORTHY TL
      REGULATION OF APOPTOSIS IN MOUSE HEPATOCYTES AND ALTERATION OF APOPTOSIS BY NONGENOTOXIC CARCINOGENS

      Cell growth & differentiation
    35. FONTANA JA; SUN RJ; RISHI AK; DAWSON MI; ORDONEZ JV; ZHANG YX; TSCHANG SH; BHALLA K; HAN ZY; WYCHE J; POIRER G; SHEIKH MS; SHROOT B; REICHERT U
      OVEREXPRESSION OF BCL-2 OR BCL-X-L FAILS TO INHIBIT APOPTOSIS MEDIATED BY A NOVEL RETINOID

      Oncology research
    36. UDA S; YOSHIMURA A; SUGENOYA Y; INUI K; TAIRA T; IDEURA T
      MESANGIAL PROLIFERATIVE NEPHRITIS IN MAN IS ASSOCIATED WITH INCREASEDEXPRESSION OF THE CELL-SURVIVAL FACTOR, BCL-2

      American journal of nephrology
    37. CHONG YY; LAU LC; LUI WO; LIM P; LIM E; TAN PH; TAN P; ONG YY
      A CASE OF T(8-14) WITH TOTAL AND PARTIAL TRISOMY-3 IN WALDENSTROM-MACROGLOBULINEMIA

      Cancer genetics and cytogenetics
    38. NAUMOVSKI L; MARTINOVSKY G; WONG C; CHANG M; RAVENDRANATH Y; WEINSTEIN H; DAHL G
      BCL-2 EXPRESSION DOES NOT CORRELATE WITH PATIENT OUTCOME IN PEDIATRICACUTE MYELOGENOUS LEUKEMIA

      Leukemia research
    39. SHIMIZU S; EGUCHI Y; KAMIIKE W; FUNAHASHI Y; MIGNON A; LACRONIQUE V; MATSUDA H; TSUJIMOTO Y
      BCL-2 PREVENTS APOPTOTIC MITOCHONDRIAL DYSFUNCTION BY REGULATING PROTON FLUX

      Proceedings of the National Academy of Sciences of the United Statesof America
    40. YOSHIMURA S; BANNO Y; NAKASHIMA S; TAKENAKA K; SAKAI H; NISHIMURA Y; SAKAI N; SHIMIZU S; EGUCHI Y; TSUJIMOTO Y; NOZAWA Y
      CERAMIDE FORMATION LEADS TO CASPASE-3 ACTIVATION DURING HYPOXIC PC12 CELL-DEATH - INHIBITORY EFFECTS OF BCL-2 ON CERAMIDE FORMATION AND CASPASE-3 ACTIVATION

      The Journal of biological chemistry
    41. WEDENBERG C; JESSLEN P; LUNDQVIST G; LUNDGREN J; HELLQUIST HB
      BASALOID-SQUAMOUS CELL-CARCINOMA OF THE MAXILLA

      Oral Oncology
    42. KAWAUCHI S; NOGUCHI S; FUKUDA T; TSUNEYOSHI M
      SUBCELLULAR-LOCALIZATION OF BCL-2 PROTEIN IN SYNOVIAL SARCOMA

      Pathology international
    43. MARSCHALEK R; NILSON I; LOCHNER K; GREIM R; SIEGLER G; GREIL J; BECK JD; FEY GH
      THE STRUCTURE OF THE HUMAN ALL-1 MLL HRX GENE

      Leukemia & lymphoma
    44. HAO XP; ILYAS M; TALBOT IC
      EXPRESSION OF BCL-2 AND P53 IN THE COLORECTAL ADENOMA-CARCINOMA SEQUENCE

      Pathobiology
    45. SUNDELIN K; JADNER M; NORBERGSPAAK L; DAVIDSSON A; HELLQUIST HB
      METALLOTHIONEIN AND FAS (CD95) ARE EXPRESSED IN SQUAMOUS-CELL CARCINOMA OF THE TONGUE

      European journal of cancer
    46. TANABE H; EGUCHI Y; KAMADA S; MARTINOU JC; TSUJIMOTO Y
      SUSCEPTIBILITY OF CEREBELLAR GRANULE NEURONS DERIVED FROM BCL-2-DEFICIENT AND TRANSGENIC MICE TO CELL-DEATH

      European journal of neuroscience
    47. COOPERSMITH CM; GORDON JI
      GAMMA-RAY-INDUCED APOPTOSIS IN TRANSGENIC MICE WITH PROLIFERATIVE ABNORMALITIES IN THEIR INTESTINAL EPITHELIUM - REENTRY OF VILLUS ENTEROCYTES INTO THE CELL-CYCLE DOES NOT AFFECT THEIR RADIORESISTANCE BUT ENHANCES THE RADIOSENSITIVITY OF THE CRYPT BY INDUCING P53

      Oncogene
    48. JAGER R; HERZER U; SCHENKEL J; WEIHER H
      OVEREXPRESSION OF BCL-2 INHIBITS ALVEOLAR CELL APOPTOSIS DURING INVOLUTION AND ACCELERATES C-MYC-INDUCED TUMORIGENESIS OF THE MAMMARY-GLANDIN TRANSGENIC MICE

      Oncogene
    49. KOIDE N; KOIKE S; ADACHI W; AMANO J; USUDA N; NAGATA T
      IMMUNOHISTOCHEMICAL EXPRESSION OF BCL-2 PROTEIN IN SQUAMOUS-CELL CARCINOMA AND BASALOID CARCINOMA OF THE ESOPHAGUS

      SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY
    50. WADA M; DOI R; HOSOTANI R; LEE JU; FUJIMOTO K; KOSHIBA T; MIYAMOTO Y; FUKUOKA S; IMAMURA M
      EXPRESSION OF BCL-2 AND PCNA IN DUCT CELLS AFTER PANCREATIC DUCT LIGATION IN RATS

      Pancreas
    51. BROWN J; HIGO H; MCKALIP A; HERMAN B
      HUMAN PAPILLOMAVIRUS (HPV)-16-E6 SENSITIZES CELLS TO ATRACTYLOSIDE-INDUCED APOPTOSIS - ROLE OF P53, ICE-LIKE PROTEASES AND THE MITOCHONDRIAL PERMEABILITY TRANSITION

      Journal of cellular biochemistry
    52. NAGAI M; FUJITA M; OHMORI M; MATSUBARA S; TANIWAKI M; HORIIKE S; TASAKA T; KOEFFLER HP; TAKAHARA J
      ESTABLISHMENT OF A NOVEL HUMAN B-CELL LINE (OZ) WITH T(14-18)(Q32-Q21) AND ABERRANT P53 EXPRESSION WAS ASSOCIATED WITH THE HOMOZYGOUS DELETIONS OF P15(INK4B) AND P16(INK4A) GENES

      Hematological oncology
    53. OHTSU M; SAKAI N; FUJITA H; KASHIWAGI M; GASA S; SHIMIZU S; EGUCHI Y; TSUJIMOTO Y; SAKIYAMA Y; KOBAYASHI K; KUZUMAKI N
      INHIBITION OF APOPTOSIS BY THE ACTIN-REGULATORY PROTEIN GELSOLIN

      EMBO journal
    54. LEVIN LA; SCHLAMP CL; SPIELDOCH RL; GESZVAIN KM; NICKELLS RW
      IDENTIFICATION OF THE BCL-2 FAMILY GENES IN THE RAT RETINA

      Investigative ophthalmology & visual science
    55. HELLQUIST HB; SUNDELIN K; DIBACCO A; TYTOR M; MANZOTTI M; VIALE G
      TUMOR-GROWTH FRACTION AND APOPTOSIS IN SALIVARY-GLAND ACINIC CELL CARCINOMAS - PROGNOSTIC IMPLICATIONS OF KI-67 AND BCL-2 EXPRESSION AND OFIN-SITU END LABELING (TUNEL)

      Journal of pathology
    56. COOPERSMITH CM; CHANDRASEKARAN C; MCNEVIN MS; GORDON JI
      BI-TRANSGENIC MICE REVEAL THAT K-RAS(VAL12) AUGMENTS A P53-INDEPENDENT APOPTOSIS WHEN SMALL-INTESTINAL VILLUS ENTEROCYTES REENTER THE CELL-CYCLE

      The Journal of cell biology
    57. WANG XN; STUDZINSKI GP
      ANTIAPOPTOTIC ACTION OF 1,25-DIHYDROXYVITAMIN D-3 IS ASSOCIATED WITH INCREASED MITOCHONDRIAL MCL-1 AND RAF-1 PROTEINS AND REDUCED RELEASE OF CYTOCHROME-C

      Experimental cell research
    58. VANDERVLIET HJJ; WEVER PC; VANDIEPEN FNJ; YONG SL; TENBERGE IJM
      QUANTIFICATION OF BAX BCL-2 RATIOS IN PERIPHERAL-BLOOD LYMPHOCYTES, MONOCYTES AND GRANULOCYTES AND THEIR RELATION TO SUSCEPTIBILITY TO ANTI-FAS (ANTI-CD95)-INDUCED APOPTOSIS/

      Clinical and experimental immunology
    59. EGUCHI Y; SHIMIZU S; TSUJIMOTO Y
      INTRACELLULAR ATP LEVELS DETERMINE CELL-DEATH FATE BY APOPTOSIS OR NECROSIS

      Cancer research
    60. OHBU M; SAEGUSA M; KOBAYASHI N; TSUKAMOTO H; MIENO H; KAKITA A; OKAYASU I
      EXPRESSION OF BCL-2 PROTEIN IN ESOPHAGEAL SQUAMOUS-CELL CARCINOMAS AND ITS ASSOCIATION WITH LYMPH-NODE METASTASIS

      Cancer
    61. LEE GH
      CORRELATION BETWEEN BCL-2 EXPRESSION AND HISTOPATHOLOGY IN DIETHYLNITROSAMINE-INDUCED MOUSE HEPATOCELLULAR TUMORS

      The American journal of pathology
    62. SPENCE P; FRANCO R; WOOD A; MOYER JA
      MECHANISMS OF APOPTOSIS AS DRUG TARGETS IN THE CENTRAL-NERVOUS-SYSTEM

      Expert opinion on therapeutic patents
    63. KANDOUZ M; GOMPEL A; THERWATH A
      BCL-2 PROTOONCOGENE, APOPTOSIS AND ONCOGENESIS - AN OVERVIEW

      International journal of oncology
    64. GIBSON L; HOLMGREEN SP; HUANG DCS; BERNAND O; COPELAND NG; JENKINS NA; SUTHERLAND GR; BAKER E; ADAMS JM; CORY S
      BCL-W, A NOVEL MEMBER OF THE BCL-2 FAMILY, PROMOTES CELL-SURVIVAL

      Oncogene
    65. SHIMIZU S; EGUCHI Y; KAMIIKE W; WAGURI S; UCHIYAMA Y; MATSUDA H; TSUJIMOTO Y
      BCL-2 BLOCKS LOSS OF MITOCHONDRIAL-MEMBRANE POTENTIAL WHILE ICE INHIBITORS ACT AT A DIFFERENT STEP DURING INHIBITION OF DEATH INDUCED BY RESPIRATORY-CHAIN INHIBITORS

      Oncogene
    66. CHHIENG DC; ROSS JS; AMBROS RA
      BCL-2 EXPRESSION AND THE DEVELOPMENT OF ENDOMETRIAL CARCINOMA

      Modern pathology
    67. HENDERSON GS; BROWN KA; PERKINS SL; ABBOTT TM; CLAYTON F
      BCL-2 IS DOWN-REGULATED IN ATYPICAL ENDOMETRIAL HYPERPLASIA AND ADENOCARCINOMA

      Modern pathology
    68. NAIK P; KARRIM J; HANAHAN D
      THE RISE AND FALL OF APOPTOSIS DURING MULTISTAGE TUMORIGENESIS - DOWN-MODULATION CONTRIBUTES TO TUMOR PROGRESSION FROM ANGIOGENIC PROGENITORS

      Genes & development
    69. PARK JR; HOCKENBERY DM
      BCL-2, A NOVEL REGULATOR OF APOPTOSIS

      Journal of cellular biochemistry
    70. SUGIMOTO T; XIAO C; HE YF; ICHIKAWA H
      BAX PROTEIN-LIKE IMMUNOREACTIVITY IN PRIMARY SENSORY AND HYPOTHALAMICNEURONS OF ADULT-RATS

      Neuroscience letters
    71. NAUMOVSKI L; CLEARY ML
      THE P53-BINDING PROTEIN 53BP2 ALSO INTERACTS WITH BCL2 AND IMPEDES CELL-CYCLE PROGRESSION AT G(2) M/

      Molecular and cellular biology
    72. OBARR S; SCHULTZ J; ROGERS J
      EXPRESSION OF THE PROTOONCOGENE BCL-2 IN ALZHEIMERS-DISEASE BRAIN

      Neurobiology of aging
    73. KURSCHNER C; MORGAN JI
      ANALYSIS OF INTERACTION SITES IN HOMOMERIC AND HETEROMERIC COMPLEXES CONTAINING BCL-2 FAMILY MEMBERS AND THE CELLULAR PRION PROTEIN

      Molecular brain research
    74. MICHAUD GY; KAMESAKI H; COSSMAN J
      EXPRESSION OF BCL-X IN T-CELLS

      Leukemia research
    75. OKA H; SATOH Y; KAWANO N; YAGISHITA S; KAMEYA T
      EXPRESSION OF BCL-2 GENE-PRODUCT IN EMBRYONAL TUMORS OF THE CENTRAL-NERVOUS-SYSTEM

      Surgical neurology
    76. NAKAMURA S; AKAZAWA K; KINUKAWA N; YAO T; TSUNEYOSHI M
      INVERSE CORRELATION BETWEEN THE EXPRESSION OF BCL-2 AND P53 PROTEINS IN PRIMARY GASTRIC LYMPHOMA

      Human pathology
    77. LINETTE GP; LI Y; ROTH K; KORSMEYER SJ
      CROSS-TALK BETWEEN CELL-DEATH AND CELL-CYCLE PROGRESSION - BCL-2 REGULATES NFAT-MEDIATED ACTIVATION

      Proceedings of the National Academy of Sciences of the United Statesof America
    78. KAKLAMANIS L; SAVAGE A; MORTENSEN N; TSIOTOS P; DOUSSISANAGNOSTOPOULOU I; BIDDOLPH S; WHITEHOUSE R; HARRIS AL; GATTER KC
      EARLY EXPRESSION OF BCL-2 PROTEIN IN THE ADENOMA-CARCINOMA SEQUENCE OF COLORECTAL NEOPLASIA

      Journal of pathology
    79. NOEL PJ; BOISE LH; GREEN JM; THOMPSON CB
      CD28 COSTIMULATION PREVENTS CELL-DEATH DURING PRIMARY T-CELL ACTIVATION

      The Journal of immunology
    80. ZANJANI HS; VOGEL MW; DELHAYEBOUCHAUD N; MARTINOU JC; MARIANI J
      INCREASED CEREBELLAR PURKINJE-CELL NUMBERS IN MICE OVEREXPRESSING A HUMAN BCL-2 TRANSGENE

      Journal of comparative neurology
    81. OKAZAWA H; SHIMIZU J; KAMEI M; IMAFUKU I; HAMADA H; KANAZAWA I
      BCL-2 INHIBITS RETINOIC ACID-INDUCED APOPTOSIS DURING THE NEURAL DIFFERENTIATION OF EMBRYONAL STEM-CELLS

      The Journal of cell biology
    82. SHIMIZU S; EGUCHI Y; KAMIIKE W; ITOH Y; HASEGAWA J; YAMABE K; OTSUKI Y; MATSUDA H; TSUJIMOTO Y
      INDUCTION OF APOPTOSIS AS WELL AS NECROSIS BY HYPOXIA AND PREDOMINANTPREVENTION OF APOPTOSIS BY BCL-2 AND BCL-X(L)

      Cancer research
    83. YAMAMURA K; KAMADA S; ITO S; NAKAGAWA K; ICHIHASHI M; TSUJIMOTO Y
      ACCELERATED DISAPPEARANCE OF MELANOCYTES IN BCL-2-DEFICIENT MICE

      Cancer research
    84. OLIE RA; BOERSMA AWM; DEKKER MC; NOOTER K; LOOIJENGA LHJ; OOSTERHUIS JW
      APOPTOSIS OF HUMAN SEMINOMA CELLS UPON DISRUPTION OF THEIR MICROENVIRONMENT

      British Journal of Cancer
    85. UEDA V; MATSUDA F; MISAWA S; TANIWAKI M
      TUMOR-SPECIFIC REARRANGEMENTS OF THE IMMUNOGLOBULIN HEAVY-CHAIN GENE IN B-CELL NON-HODGKINS-LYMPHOMA DETECTED BY IN-SITU HYBRIDIZATION

      Blood
    86. DIEBOLD J; BARETTON G; FELCHNER M; MEIER W; DOPFER K; SCHMIDT M; LOHRS U
      BCL-2 EXPRESSION, P53 ACCUMULATION, AND APOPTOSIS IN OVARIAN CARCINOMAS

      American journal of clinical pathology
    87. KOUVIDOU C; KANAVAROS P; PAPAIOANNOU D; STATHOPOULOS E; SOTSIOU F; DATSERIS G; TZARDI M; KITTAS C; DELIDES G
      EXPRESSION OF BCL-2 AND P53 PROTEINS IN NASOPHARYNGEAL CARCINOMA - ABSENCE OF CORRELATION WITH THE PRESENCE OF EBV ENCODED EBER1-2 TRANSCRIPTS AND LATENT MEMBRANE PROTEIN-1

      JCP. Clinical molecular pathology
    88. UMEMURA S; KAWAI K; OSAMURA RY; TSUTSUMI Y
      ANTIGEN RETRIEVAL FOR BCL-2 PROTEIN IN FORMALIN-FIXED, PARAFFIN-EMBEDDED SECTIONS

      Pathology international
    89. OHTA K; IWAI K; KASAHARA Y; TANIGUCHI N; KRAJEWSKI S; REED JC; MIYAWAKI T
      IMMUNOBLOT ANALYSIS OF CELLULAR EXPRESSION OF BCL-2 FAMILY PROTEINS, BCL-2, BAX, BCL-X AND MCL-1, IN HUMAN PERIPHERAL-BLOOD AND LYMPHOID-TISSUES

      International immunology
    90. SHINTO Y; MORIMOTO M; KATSUMATA M; UCHIDA A; AOZASA K; OKAMOTO M; KUROSAWA T; OCHI T; GREENE MI; TSUJIMOTO Y
      MOLONEY MURINE LEUKEMIA-VIRUS INFECTION ACCELERATES LYMPHOMAGENESIS IN E-MU-BCL-2 TRANSGENIC MICE

      Oncogene
    91. OKAN I; WANG YS; CHEN F; HU LF; IMREH S; KLEIN G; WIMAN KG
      THE EBV-ENCODED LMP1 PROTEIN INHIBITS P53-TRIGGERED APOPTOSIS BUT NOTGROWTH ARREST

      Oncogene
    92. SCHULER M; HUBER C; PESCHEL C
      CYTOKINES IN THE PATHOPHYSIOLOGY AND TREATMENT OF CHRONIC B-CELL MALIGNANCIES - A REVIEW

      Annals of hematology
    93. KORSMEYER SJ; YIN XM; OLTVAI ZN; VEISNOVACK DJ; LINETTE GP
      REACTIVE OXYGEN SPECIES AND THE REGULATION OF CELL-DEATH BY THE BCL-2GENE FAMILY

      Biochimica et biophysica acta. Molecular basis of disease
    94. RODRIGUEZVILLANUEVA J; COLOME MI; BRISBAY S; MCDONNELL TJ
      THE EXPRESSION AND LOCALIZATION OF BCL-2 PROTEIN IN NORMAL SKIN AND IN NONMELANOMA SKIN CANCERS

      Pathology research and practice
    95. ERLACHER L; MAIER R; ULLRICH R; KIENER H; ARINGER M; MENSCHIK M; GRANINGER W
      DIFFERENTIAL EXPRESSION OF THE PROTOONCOGENE BCL-2 IN NORMAL AND OSTEOARTHRITIC HUMAN ARTICULAR-CARTILAGE

      Journal of rheumatology
    96. IKEGAKI N; KATSUMATA M; TSUJIMOTO Y; NAKAGAWARA A; BRODEUR GM
      RELATIONSHIP BETWEEN BCL-2 AND MYC GENE-EXPRESSION IN HUMAN NEUROBLASTOMA

      Cancer letters
    97. HOCKENBERY DM
      BCL-2, A NOVEL REGULATOR OF CELL-DEATH

      BioEssays
    98. CHITTENDEN T; FLEMINGTON C; HOUGHTON AB; EBB RG; GALLO GJ; ELANGOVAN B; CHINNADURAI G; LUTZ RJ
      A CONSERVED DOMAIN IN BAK, DISTINCT FROM BH1 AND BH2, MEDIATES CELL-DEATH AND PROTEIN-BINDING FUNCTIONS

      EMBO journal
    99. KURSCHNER C; MORGAN JI
      THE CELLULAR PRION PROTEIN (PRP) SELECTIVELY BINDS TO BCL-2 IN THE YEAST 2-HYBRID SYSTEM

      Molecular brain research
    100. KORSMEYER SJ
      REGULATORS OF CELL-DEATH

      Trends in genetics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/10/20 alle ore 13:09:03